UBS Upgrades IMCD to Buy Rating, Boosts PT

08:38 AM EDT, 07/14/2026 (MT Newswires) -- UBS on Tuesday upgraded Dutch specialty chemicals and ingredients company IMCD (IMCD.AS) to buy from neutral and raised its price target to 100 euros from 85 euros. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)